Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) Research & Development (2017 - 2025)

Historic Research & Development for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to -$5.7 million.

  • Bioceres Crop Solutions' Research & Development fell 2958.75% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 2157.19%. This contributed to the annual value of $14.9 million for FY2025, which is 1320.03% down from last year.
  • According to the latest figures from Q3 2025, Bioceres Crop Solutions' Research & Development is -$5.7 million, which was down 2958.75% from $27.2 million recorded in Q2 2025.
  • In the past 5 years, Bioceres Crop Solutions' Research & Development registered a high of $29.0 million during Q2 2024, and its lowest value of -$5.7 million during Q3 2025.
  • Over the past 5 years, Bioceres Crop Solutions' median Research & Development value was -$3.5 million (recorded in 2022), while the average stood at $3.0 million.
  • Per our database at Business Quant, Bioceres Crop Solutions' Research & Development plummeted by 1242595161.29% in 2022 and then skyrocketed by 12889.01% in 2023.
  • Quarter analysis of 5 years shows Bioceres Crop Solutions' Research & Development stood at -$1.4 million in 2021, then tumbled by 149.84% to -$3.5 million in 2022, then decreased by 5.36% to -$3.6 million in 2023, then fell by 15.09% to -$4.2 million in 2024, then crashed by 36.34% to -$5.7 million in 2025.
  • Its Research & Development stands at -$5.7 million for Q3 2025, versus $27.2 million for Q2 2025 and -$3.7 million for Q1 2025.